FDA inspection

Narodowe Centrum Badan Jadrowych: FDA inspection ending May 24, 2024

FDA inspection 1246113 · Voluntary Action Indicated (VAI) · Otwock

Key facts

Inspection ID 1246113
Firm Narodowe Centrum Badan Jadrowych
FEI number 3008592343
Address Radioisotope Centre Polatom, Andrzej Soltan 7 Street
City Otwock
Country Poland
Fiscal year 2024
Inspection end date May 24, 2024
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections